FOCUS PI Hypromellose 0 — Class II drug recall D-0874-2026
Ongoing recall by Aurolab Trust, reported 2026-10-07, distributed in VA. Lack of Assurance of Sterility
| Recall number | D-0874-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aurolab Trust, Madurai, India |
| Recall initiated | 2026-09-17 |
| Classified | 2026-09-28 |
| Reported by FDA | 2026-10-07 |
| Distributed | VA |
| Quantity | 25,220 bottles |
| Reason classes | sterility |
| NDC | 82724-0007, 82724-0007-19 |
| Lot numbers | 6B093FI, 6F511F1 |
| Expiration dates | 2028-04-01, 2028-05-15 |
Product
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0874-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-13. Not affiliated with or endorsed by FDA. Not medical or legal advice.